Last reviewed · How we verify
NCT05464121
A Blended Intervention for Adjustment Disorder.
NA trial testing • Blended treatment for AjD combining a self-applied Internet-based program (TAO) with face-to-face sessions via videoconference. in Adjustment Disorders in 41 participants. Completed in 1 November 2025.
1 June 2025
Quick facts
| Lead sponsor | Universitat Jaume I |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 41 |
| Start date | 18 November 2022 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 November 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- • Blended treatment for AjD combining a self-applied Internet-based program (TAO) with face-to-face sessions via videoconference.
Conditions studied
- Adjustment Disorders — all drugs for Adjustment Disorders →
Sponsor
Universitat Jaume I — full company profile →
Who can join
18 and older, any sex, with Adjustment Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the feasibility (including usability and satisfaction) and preliminary effectiveness of a blended intervention for Adjustment Disorder. This intervention combines a self-applied Internet-based program (TAO) with face-to-face sessions with a therapist via videoconference.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A blended intervention for adjustment disorder: Study protocol for a feasibility trial.
Fernández-Buendía S, Cuijpers P, Grimaldos J, Díaz-García A, et al · · 2024 · cited 1× · PMID 38313142 · DOI 10.1016/j.invent.2024.100715
Verify or expand the search:
- PubMed search for NCT05464121
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adjustment Disorders
Currently open trials in the same condition.
- NCT06885554 — Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation · NA · recruiting
- NCT06843044 — Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders · Phase 4 · recruiting
- NCT05963308 — Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the H · NA · recruiting
- NCT04900064 — Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial · NA · recruiting
Other Universitat Jaume I trials
Trials by the same sponsor.
- NCT07202975 — RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence · NA · not yet recruiting
- NCT07345117 — Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Commun · NA · not yet recruiting
- NCT06932120 — Technology-supported Interventions for Prolonged Grief Disorder (PGD) · NA · recruiting
- NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
- NCT06839573 — Effectiveness of Immersive Virtual Reality in Nursing Students' Learning · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05464121 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitat Jaume I
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05464121.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing